Avita Medical's ReCell regenerative medicine technology.

Avita taps investors for $17m

The company commercialising an innovative spray-on burns treatment co-developed by medical entrepreneur Fiona Wood has launched a $17 million capital raising.


(existing subscribers)

The password field is case sensitive.
Request new password

Sign up for free emails

Complete your details below to receive our twice-daily news emails and our BN Weekender.

Thanks! This question prevents spammers...
Enter the characters shown in the image.

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/12/17

1 year TSR5 year TSR
311thPura Vida Energy25%-42%
568thAdvanced Braking Technology-14%-20%
597thSuda Pharmaceuticals-20%-14%
719thResource Development Group-47%-33%
721stAvita Medical-48%-10%
696 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$75k Bought
$10k Bought
$5k Bought
Total value as at the date of the transaction
Source: Morningstar


89th↑Pura Vida Energy$9.4m
90th↓Resource Development Group$9.3m
91st↑Avita Medical$8.0m
92nd↓Advanced Braking Technology$7.7m
93rd↓Suda Pharmaceuticals$7.3m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Avita Medical

243rdTim Rooney$506k
361stAndrew Quick$366k
646thLorraine Glover$216k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer